IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC) Meeting Abstract


Authors: Harbeck, N.; Zhang, H.; Barrios, C. H.; Saji, S.; Jung, K. H.; Hegg, R.; Koehler, A.; Sohn, J.; Iwata, H.; Telli, M. L.; Ferrario, C.; Punie, K.; Penault-Llorca, F.; Patel, S.; Nguyen Duc, A.; Liste-Hermoso, M.; Maiya, V.; Molinero, L.; Chui, S. Y.; Mittendorf, E.
Abstract Title: IMpassion031: Results from a phase III study of neoadjuvant (neoadj) atezolizumab + chemotherapy in early triple-negative breast cancer (TNBC)
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S1144
Language: English
ACCESSION: WOS:000573469102637
DOI: 10.1016/j.annonc.2020.08.2239
PROVIDER: wos
Notes: Meeting Abstract: LBA11-- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hong Zhang
    54 Zhang